Filing Details
- Accession Number:
- 0001179110-15-016635
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-21 21:31:43
- Reporting Period:
- 2015-12-21
- Filing Date:
- 2015-12-21
- Accepted Time:
- 2015-12-21 21:31:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061027 | Sunesis Pharmaceuticals Inc | SNSS | Pharmaceutical Preparations (2834) | 943295878 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1461466 | Dayton Misfeldt | C/O Bay City Capital Llc 750 Battery Street, Suite 400 San Francisco CA 94111 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-21 | 1,717,275 | $0.84 | 7,234,441 | No | 4 | P | Indirect | See footnotes. |
| Common Stock | Acquisiton | 2015-12-21 | 32,725 | $0.84 | 137,859 | No | 4 | P | Indirect | See footnotes. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnotes. |
| No | 4 | P | Indirect | See footnotes. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,515 | Indirect | See footnote. |
Footnotes
- The reporting person is a Managing Director of Bay City Capital LLC, a Delaware limited liability company ("BCC"). BCC is the manager of Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"). Management V is the general partner of Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V") and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V") and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held. Mr. Misfeldt, BCC and Management V disclaim beneficial ownership with respect to the securities reported in this Form 4, except to the extent of their pecuniary interest therein.
- The securities are held by Fund V.
- The securities are held by Co-Investment V.
- The securities are held by BCC.
Billionaire Hedge Funds
